Rapamycin Low-Dose Safety Profile in Healthy Elderly
Weekly low-dose rapamycin was well-tolerated in adults over 70, with improved immune function markers.
Weekly low-dose rapamycin was well-tolerated in adults over 70, with improved immune function markers.
An 8-week program combining diet, sleep, exercise, and stress management reversed biological age by an average of 3 years.
NMN supplementation increased blood NAD+ levels by 40% in middle-aged adults, with improvements in insulin sensitivity.
A combination of dasatinib and quercetin cleared senescent cells in aged mice, resulting in improved physical function and extended healthy lifespan by approximately 30%.